Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 8 | 2025 | 449 | 2.110 |
Why?
|
| Polymers | 3 | 2020 | 151 | 1.080 |
Why?
|
| Paclitaxel | 2 | 2020 | 64 | 1.020 |
Why?
|
| Drug Delivery Systems | 7 | 2025 | 273 | 0.960 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2020 | 134 | 0.930 |
Why?
|
| Antineoplastic Agents | 3 | 2025 | 979 | 0.900 |
Why?
|
| Polyesters | 2 | 2014 | 26 | 0.840 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 159 | 0.810 |
Why?
|
| Receptor, erbB-2 | 1 | 2025 | 149 | 0.810 |
Why?
|
| Drug Carriers | 3 | 2025 | 169 | 0.730 |
Why?
|
| Breast Neoplasms | 3 | 2025 | 1679 | 0.720 |
Why?
|
| Naltrexone | 3 | 2011 | 34 | 0.680 |
Why?
|
| Particle Size | 5 | 2025 | 267 | 0.680 |
Why?
|
| Computer-Aided Design | 2 | 2020 | 11 | 0.640 |
Why?
|
| Lactams, Macrocyclic | 1 | 2020 | 8 | 0.640 |
Why?
|
| Narcotic Antagonists | 2 | 2011 | 78 | 0.620 |
Why?
|
| Benzoquinones | 1 | 2020 | 38 | 0.620 |
Why?
|
| Technology, Pharmaceutical | 2 | 2015 | 32 | 0.580 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 233 | 0.560 |
Why?
|
| Cross-Linking Reagents | 2 | 2017 | 51 | 0.560 |
Why?
|
| Delayed-Action Preparations | 2 | 2014 | 72 | 0.500 |
Why?
|
| Chemistry, Pharmaceutical | 4 | 2017 | 93 | 0.480 |
Why?
|
| Drug Industry | 1 | 2015 | 18 | 0.480 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2025 | 385 | 0.470 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 436 | 0.400 |
Why?
|
| Surface Properties | 3 | 2020 | 157 | 0.370 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 475 | 0.340 |
Why?
|
| Microspheres | 1 | 2011 | 49 | 0.340 |
Why?
|
| Nanotechnology | 2 | 2025 | 176 | 0.300 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 585 | 0.200 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 2598 | 0.200 |
Why?
|
| Hydrogels | 1 | 2003 | 55 | 0.190 |
Why?
|
| Trophoblasts | 1 | 2022 | 31 | 0.180 |
Why?
|
| HIV Infections | 1 | 2015 | 2535 | 0.180 |
Why?
|
| Education, Pharmacy | 1 | 2021 | 56 | 0.160 |
Why?
|
| Capsules | 1 | 2020 | 25 | 0.160 |
Why?
|
| Students, Pharmacy | 1 | 2021 | 57 | 0.160 |
Why?
|
| Humans | 7 | 2025 | 42113 | 0.150 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 23 | 0.150 |
Why?
|
| Cell Proliferation | 1 | 2025 | 1420 | 0.140 |
Why?
|
| Drug Resistance | 1 | 2019 | 97 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 150 | 0.140 |
Why?
|
| Acetals | 1 | 2017 | 2 | 0.130 |
Why?
|
| Benzaldehydes | 1 | 2017 | 8 | 0.130 |
Why?
|
| Female | 4 | 2025 | 23980 | 0.130 |
Why?
|
| Micelles | 1 | 2017 | 36 | 0.130 |
Why?
|
| Hydrolysis | 1 | 2017 | 98 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 491 | 0.110 |
Why?
|
| Time Factors | 2 | 2011 | 1845 | 0.110 |
Why?
|
| Molecular Structure | 1 | 2017 | 560 | 0.110 |
Why?
|
| RNA Interference | 1 | 2015 | 246 | 0.110 |
Why?
|
| Quality of Life | 1 | 2019 | 598 | 0.100 |
Why?
|
| Ovary | 1 | 2014 | 112 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 158 | 0.100 |
Why?
|
| Breast | 1 | 2014 | 139 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2014 | 403 | 0.100 |
Why?
|
| Animals | 3 | 2015 | 16694 | 0.090 |
Why?
|
| Transition Temperature | 1 | 2011 | 9 | 0.090 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 52 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2011 | 168 | 0.090 |
Why?
|
| Polyglycolic Acid | 1 | 2011 | 48 | 0.080 |
Why?
|
| Solubility | 1 | 2011 | 134 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2011 | 110 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 406 | 0.080 |
Why?
|
| Temperature | 1 | 2011 | 314 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 65 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2008 | 282 | 0.070 |
Why?
|
| Alcoholism | 1 | 2011 | 292 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 458 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2008 | 369 | 0.060 |
Why?
|
| Methacrylates | 1 | 2003 | 6 | 0.050 |
Why?
|
| Azo Compounds | 1 | 2003 | 17 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 64 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 448 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 112 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 205 | 0.040 |
Why?
|
| Placenta | 1 | 2022 | 113 | 0.040 |
Why?
|
| Rats | 1 | 2008 | 3701 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2021 | 100 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2022 | 548 | 0.040 |
Why?
|
| Universities | 1 | 2021 | 539 | 0.030 |
Why?
|
| Pregnancy | 1 | 2022 | 1733 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2466 | 0.030 |
Why?
|
| Male | 1 | 2008 | 22745 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2002 | 82 | 0.010 |
Why?
|